Bloomberg: Malaria Vaccine Took 30 Years. It’s Still a Work in Progress “After more than three decades of work and almost $1 billion of investment, GlaxoSmithKline Plc and its partners are ready to deploy a vaccine for malaria, the mosquito-borne disease that kills almost half a million people each year.…

The Telegraph: World watches as U.K. announces it will drop key childhood vaccine to two doses “The U.K. is set to become the first country in the world to cut a key childhood vaccine from three to two doses in a move that experts hope will encourage poorer countries to…

World Economic Forum: 3 ways Africa can improve the health of women and children Temitayo Erogbogbo, director of advocacy at MSD For Mothers, outlines three ways African governments can engage the private sector to reduce maternal mortality and improve the health of women and children: “1. Optimizing innovative financing tools…

Health-e News: Tackling the high price of medicine “Profit seems to be the only logic driving medicine prices, with some African countries paying more for medicine than European countries, and U.S. citizens paying some of the highest medicine prices in the world. There are global efforts to rein in excessive…

Health Policy Watch: WHO-led Fair Pricing Forum Gathers Diverse Groups To Improve Drug Access “A diverse group of civil society, industry, and government representatives convened [Thursday] at the WHO-led 2nd Fair Pricing Forum in Johannesburg, South Africa, in the quest for new solutions that can unlock people’s access to desperately…

Agence France-Presse: Push to cure hepatitis B, a neglected disease (4/10). Al Jazeera: Death toll from devastating Cyclone Idai rises above 1,000 (4/10). Borgen Magazine: How Drug Manufacturers are Treating Neglected Tropical Diseases (Sharek, 4/10). Malay Mail: Rights advocates worry conservatism hampering women’s sexual, reproductive health (Zurairi AR, 4/11). NPR:…

Health-e News: MSF: Secret medicine prices cost lives Candice Sehoma, Southern Africa Access Campaign advocacy officer at Doctors Without Borders (MSF), and Gaelle Krikorian, head of policy at the MSF Access Campaign “The WHO’s 2nd Fair Pricing Forum meeting, being convened in Johannesburg on 11-13 April, brings together governments, academics,…

Devex: Will new TB treatments reach those who need them most? “Pharma giant GlaxoSmithKline is pursuing new treatments for tuberculosis but insists it will need support from governments and funding agencies if it is to get them to patients in lower-income countries, the head of its global health unit, David…

USAID: Written Statement of USAID Administrator Mark Green before the House Foreign Affairs Committee In written testimony for a hearing in the House Foreign Affairs Committee on USAID’s FY 2020 budget request, USAID Administrator Mark Green discussed key aspects of the request, including the U.S. humanitarian response to Venezuela, Tropical…

STAT: Creating new antimicrobial drugs will require governments working with industry Thomas B. Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and chair of the AMR Industry Alliance “As the number of infections resistant to antimicrobial drugs continues to rise around the world, and with…